ReviewCurrent opinion in pediatrics2025
Hypertension and vascular health in the young.
Review in Current opinion in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review examines the role of vascular health in children and adolescents with systemic hypertension. Like other areas of target organ damage (TOD), arterial dysfunction can have deleterious effects over time, leading to adverse cardiovascular events such as myocardial infarction or stroke as an adult. RECENT
findingsLiterature in the last few years has focused on TOD to the vascular tree in pediatric patients with hypertension. These data also included vascular dysfunction in ambulatory and masked hypertension, particularly in secondary causes of hypertension, which emphasize the importance of ambulatory BP monitoring in these patients. While subclinical TOD exists early on, longitudinal studies that follow diverse populations with hypertension from childhood into late adulthood are needed to determine if abnormal vasculature is independently associated with suboptimal cardiovascular outcomes. Consistent conduct of these tests would more formally incorporate them into pediatric clinical practice. SUMMARY: Hypertension is a chronic medical condition that needs a multipronged treatment approach. The vasculature is an important yet understudied area of TOD. Longitudinal studies in this realm could link subclinical disease in youth to adult adverse events and develop more precise management to mitigate these events and to enable a better quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.